Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapies help treat female hair loss, but results are slow and vary.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Hair transplantation is the only permanent solution for female pattern hair loss and can greatly improve quality of life with careful planning.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Acne in children varies by age and severity, requires a pediatric treatment approach, and may need diagnostic evaluation for underlying conditions.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Overt hyperthyroidism is the most common thyroid disorder, especially in women.

Seborrheic alopecia in adolescents is linked to hormones, stress, and lifestyle, and can be treated with medication, lifestyle changes, and therapy.

Most people in Alahsa, Saudi Arabia, have low awareness of thyroid disease symptoms and risk factors.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Wildebeest stress and hormone levels are influenced by food availability, human presence, and reproductive cycles.

L-Cystine and L-Cystine with Kera-Diet® safely improved hair and nail quality in healthy women.

16.60% of patients had hypothyroidism, more common in females and those over 50.

Iron supplements combined with Quilib lotion effectively treat hair loss in people with iron deficiency anemia.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Nuclear Factor I-C is important for controlling hair growth by affecting the TGF-β1 pathway.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Pregnancy increases certain GABA_A receptors in rat brains, influenced by steroid levels.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.